Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, Expired product administered, Investigation, Laboratory test, Liver function test
Clinical narrative: Expired vaccine used; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 025L2OA and Q1QM2QA) for COVID-19 vaccination.     The patient's past medical history included Parotitis (Left), Colitis, Dehydration, Raynauds, Gout (Chronic tophaceous gout), Cellulitis (Finger, right 5th), Basal cell carcinoma (left medial malleolus and ankle), Vitamin D deficiency, Talus fracture (unspecified fracture of left talus, sequela), Hypocalcemia, Fracture (wound left medial malleolus), Pain in joint (Involving foot, left), Diarrhea (Chronic), Pain foot (Left second toe), Renal insufficiency, Sialoadenitis (right parotid), Angiodysplasia (Angiodysplasia of colon), Rectal bleeding, Thrombophilia (Hypercoagulable state, Primary), Anemia, DVT (Left gastrocnemius vein), Pulmonary infarction (Bilateral pulmonary embolism and infraction), Fracture (Fracture, right proximal humerus comminuted and non displaced), Leukocytosis, Barrett's esophagus, Renal insufficiency (Due to NSAIDS), Low back pain (chronic), Hypertriglyceridemia, Gout, Glaucoma, Anxiety, GERD, Hyperlipidemia, Alcoholism, Tobacco user, UTI and Injury (Injury to left Index finger). Previously administered products included for Immunisation: Fluzone on 09-Jan-2014 and Fluzone on 20-Sep-2016; for Product used for unknown indication: dermatitis. Past adverse reactions to the above products included Dermatitis with dermatitis; and No adverse event with Fluzone and Fluzone. Concurrent medical conditions included Impingement syndrome shoulder, Hypertension, Drug hypersensitivity (BACTRIM(SULFAMETHOXAZOLE-TRIMETHOPRIM TABS)(severe)), Drug hypersensitivity (Levaquin(moderate)), Drug hypersensitivity (alloprinol tabs(moderate)), Penicillin allergy (Penicillin v Potassium tab, mild) and Drug hypersensitivity (ciprofloxacin HCL(Mild)). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, FEBUXOSTAT for Gout, PARACETAMOL (TYLENOL EXTRA STRENGTH) for Low back pain, PARACETAMOL (TYLENOL ARTHRITIS) and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for Pain, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), DEXLANSOPRAZOLE (DEXILANT), CALCIUM, LISINOPRIL, VENLAFAXINE HYDROCHLORIDE, PREDNISONE, COLCHICINE (COLCRYS) and APIXABAN (ELIQUIS) for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, C-reactive protein increased: elevated (High) Elevated. On an unknown date, Investigation: results not reported Screening for breast cancer, cervical cancer, osteoporosis, skin cancer, colon cancer.. On an unknown date, Laboratory test: results not reported Results not reported. On an unknown date, Liver function test: abnormal (abnormal) abnormal. On an unknown date, Physical examination: results not reported Routine. On an unknown date, Red blood cell sedimentation rate: elevated (High) Elevated.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had reported history of Observation and evaluation for suspected exposure to other biological agent, Preoperative examination and Antihyperlipidemic use, long term.  No treatment information was provided.  Dose administered after 30-day Use By Date or after manufacturer date of expiry